Home » Topics » BioWorld Science

BioWorld Science
RSS

Ruhr University Bochum presents new compounds for treating axonal damage

March 3, 2022

New SLC10A2/SLC10A1 inhibitors identified at Albireo

March 3, 2022

Sitryx Therapeutics describes nuclear factor erythroid 2-related factor 2 activators

March 3, 2022

RUNX1 targeting shows promise for treating aggressive PDAC

March 3, 2022

Researchers present CX-10759 anti-IgE antibody for hypersensitivity

March 3, 2022

Targeting PD-1/PD-L1 pathway prevents allergic immune response

March 2, 2022

Neuropathy may unify disparate long COVID symptoms

March 2, 2022

HuR ablation ameliorates allergen-induced asthmatic symptoms

March 2, 2022

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

March 2, 2022

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

March 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...